BDOcterio 20 mg contains octreotide, a synthetic version of a natural hormone called somatostatin. This medication is designed to control the overproduction of certain hormones and secretions in the body. It is most commonly used in conditions where hormone regulation is disrupted, such as acromegaly and certain neuroendocrine tumors. BDOcterio is typically given as a long-acting intramuscular injection, often administered every four weeks.

Octreotide offers relief from debilitating symptoms such as diarrhea, flushing, and hormonal imbalances, improving both comfort and quality of life in affected patients.

Mechanism of Action

Octreotide mimics the natural effects of somatostatin by binding to somatostatin receptors found on cells in various organs. Once bound, it inhibits the release of several hormones and secretory substances, including:

• Growth hormone

• Insulin and glucagon

• Serotonin and vasoactive intestinal peptide

• Gastrin and other gastrointestinal peptides

By doing so, octreotide reduces excessive hormone production and abnormal secretions that are typically responsible for the symptoms in diseases such as acromegaly or carcinoid syndrome.

Uses

BDOcterio is used in a range of hormone-related and tumor-related conditions, including:

• Acromegaly, to reduce high levels of growth hormone when surgery or radiotherapy is not suitable

• Neuroendocrine tumors, especially those originating in the gastrointestinal tract or pancreas, to control hormone secretion and tumor-related symptoms

• Carcinoid syndrome, to reduce episodes of flushing, diarrhea, and wheezing

• VIPomas, which are rare tumors causing severe watery diarrhea

  Adverse Effects

  While octreotide is generally well tolerated, it may cause side effects due to its influence on digestive and metabolic functions.

  Common Side Effects

  • Abdominal discomfort or cramps

  • Nausea and bloating

  • Fatty stools or diarrhea

  • Pain or swelling at the injection site

  • Headache